Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eton Pharmaceuticals, Inc.

16.84
-0.4100-2.38%
Post-market: 16.840.00000.00%19:02 EDT
Volume:404.20K
Turnover:6.83M
Market Cap:451.61M
PE:-96.16
High:17.42
Open:17.11
Low:16.53
Close:17.25
Loading ...

Eton Pharmaceuticals Inc. CEO Sean Brynjelsen Reports Disposal of Common Shares

Reuters
·
06 Jun

Eton Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
29 May

Eton Pharmaceuticals Secures FDA Approval for KHINDIVI™ Oral Solution as Treatment for Pediatric Adrenal Insufficiency

Reuters
·
29 May

Eton Pharmaceuticals Announces U.S. FDA Approval for Khindivi™ (Hydrocortisone) Oral Solution

THOMSON REUTERS
·
29 May

Eton Pharmaceuticals Inc: Commercial Launch Expected Week of June 2

THOMSON REUTERS
·
29 May

Eton Pharmaceuticals Price Target Raised to $26.00/Share From $24.00 by B. Riley Securities

Dow Jones
·
17 May

B. Riley Raises Price Target on Eton Pharmaceuticals to $26 From $24, Keeps Buy Rating

MT Newswires Live
·
16 May

Eton Pharmaceuticals Is Maintained at Buy by Craig-Hallum

Dow Jones
·
15 May

Eton Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Eton Pharmaceuticals Q1 Non-GAAP EPS, Revenue Increase

MT Newswires Live
·
14 May

Eton Pharmaceuticals Q1 Adj. EPS $0.07 Beats $0.05 Estimate, Sales $17.28M Beat $15.13M Estimate

Benzinga
·
14 May

BRIEF-Eton Pharmaceuticals Q1 Net Income USD -1.572 Million

Reuters
·
14 May

Eton Pharmaceuticals Reports Q1 2025 Revenue Surge of 76%, Achieves Non-GAAP EPS of $0.07 Despite GAAP EPS Loss of $(0.06)

Reuters
·
14 May

Eton Pharmaceuticals Q1 Income From Operations USD -470 Thousand

THOMSON REUTERS
·
14 May

Eton Pharmaceuticals Inc expected to post earnings of 5 cents a share - Earnings Preview

Reuters
·
10 May

Eton Pharmaceuticals Inc expected to post earnings of 2 cents a share - Earnings Preview

Reuters
·
02 May

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

GlobeNewswire
·
02 May

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release

Zacks
·
01 May

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Apellis Pharmaceuticals (APLS) and Eton Pharmaceuticals (ETON)

TIPRANKS
·
28 Apr

Eton Pharmaceuticals Submits NDA to FDA for ET-600 to Treat Central Diabetes Insipidus

MT Newswires Live
·
28 Apr